BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12149421)

  • 21. NK cell triggering by the human costimulatory molecules CD80 and CD86.
    Wilson JL; Charo J; Martín-Fontecha A; Dellabona P; Casorati G; Chambers BJ; Kiessling R; Bejarano MT; Ljunggren HG
    J Immunol; 1999 Oct; 163(8):4207-12. PubMed ID: 10510357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-12-activated NK cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells.
    Geldhof AB; Moser M; De Baetselier P
    Adv Exp Med Biol; 1998; 451():203-10. PubMed ID: 10026873
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
    Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
    J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
    Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
    Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
    Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
    Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule.
    Stanley AJ; Gough MJ; Banks RE; Selby PJ; Patel PM
    Cancer Immunol Immunother; 2001 Jul; 50(5):260-8. PubMed ID: 11499809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines.
    Frisan T; Donati D; Cervenak L; Wilson J; Masucci MG; Bejarano MT
    Int J Cancer; 1999 Dec; 83(6):772-9. PubMed ID: 10597194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
    Morel E; Bellón T
    J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice.
    Smyth MJ; Snook MB
    Cell Immunol; 1999 Aug; 196(1):51-9. PubMed ID: 10486155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells.
    Geldhof AB; Moser M; Lespagnard L; Thielemans K; De Baetselier P
    Blood; 1998 Jan; 91(1):196-206. PubMed ID: 9414285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis.
    Ferlazzo G; Semino C; Melioli G
    Immunol Lett; 2001 Feb; 76(1):37-41. PubMed ID: 11222911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses.
    Glas R; Franksson L; Une C; Eloranta ML; Ohlén C; Orn A; Kärre K
    J Exp Med; 2000 Jan; 191(1):129-38. PubMed ID: 10620611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer clones recognize specific soluble HLA class I molecules.
    Carbone E; Terrazzano G; Colonna M; Tuosto L; Piccolella E; Franksson L; Palazzolo G; Pérez-Villar JJ; Fontana S; Kärre K; Zappacosta S
    Eur J Immunol; 1996 Mar; 26(3):683-9. PubMed ID: 8605938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.
    Vance RE; Tanamachi DM; Hanke T; Raulet DH
    Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells.
    Multhoff G; Mizzen L; Winchester CC; Milner CM; Wenk S; Eissner G; Kampinga HH; Laumbacher B; Johnson J
    Exp Hematol; 1999 Nov; 27(11):1627-36. PubMed ID: 10560910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.